BETTERLIFE PHARMA INC. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/aaab74fa-7461-4cc0-b133-2a8c20c570af/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | — | 2018-02-01 – 2019-01-31 | evidence 0001477932-19-002311 |
| FY 2017 | — | 2017-02-01 – 2018-01-31 | evidence 0001477932-19-002311 |
| FY 2016 | $-6.0M | 2016-02-01 – 2017-01-31 | evidence 0001477932-17-002007 |
| FY 2015 | $-10.3M | 2015-02-01 – 2016-01-31 | evidence 0001477932-17-002007 |
| FY 2014 | $-117.5k | 2014-02-01 – 2015-01-31 | evidence 0001477932-16-009996 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).